Please login to the form below

Not currently logged in
Email:
Password:
From: Sales

CHMP thumbs up for Novo's obesity drug Saxenda

Novo Nordisk headquartersDiabetes drug liraglutide on course for new indication in EU

From: Sales

Antibiotics among 7 new drugs backed by EMA

EU flagThe Medicines Company’s Orbactiv and Cubist’s Sivextro set for European approval

From: Sales

FDA panel backs new antifungal Cresemba

FDA headquarters White OakBasilea/Astellas drug tipped to become a $500m product

From: Sales

NICE heart attack recommendation for Xarelto

Bayer Xarelto rivaroxaban 2.5Bayer drug on course for another blood clot indication in England and Wales

Sharing the 'chimp' and its effect on decision-marking

Pharma needs to learn how to dial up its emotional connectivity

Pharma can learn to invent like an entrepreneur

Why pharma firms don’t always have to behave like corporations

Pfizer strikes genetic research deal with 23andMe

Lupus study and research community forms just one part of their collaboration

23andMe genetic testing kit

Grayling CEO Pete Pedersen resigns

He steps down after two years in role at Hunstworth company

Pete-Pedersen-grayling

Sustaining relationships

Do you really understand the KOLs you work with?

building relationships

Pfizer names head of Germany business

Peter Albiez has been with pharma company since 1996

Peter Albiez, Pfizer

Novartis forms digital health investment company

Expands work with Tricorder prize firm to develop 'beyond-the-pill' initiatives

Novartis Science Discovery Unbound Flipboard magazine

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clinigen

Clinigen Global Access Programs specializes in the consultancy, development, management and implementation of access programs across the product lifecycle for...

Latest intelligence

How ethical is your brand plan? Introducing the hEQ.
Assess your brand plan’s Healthcare Ethics Quotient and see how these questions can give your brand plan a new perspective and engage your internal teams and external customers....
solution_options.png
Why e-detailing must give options to healthcare professionals
We know, we know. You want to talk about your treatment right away, but this really is an essential step that will make your e-detailing even more credible....
Is obesity really a problem in Brazil?
Obesity is on the rise in low- and middle-income countries, particularly in urban settings...